CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Aldosterone

醛固酮 杂质对照品Aldosterone Impurities

32 个杂质条目32 impurity entries

本页汇总 醛固酮 的 32 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 32 impurity reference standards of Aldosterone. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 醛固酮(Aldosterone)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsEstablishment and Validation of Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method for Aldosterone Quantification in Feline Serum with Reference Interval Determination
    Animals : an open access journal from MDPI · 2025 · Furlanello T et al.  ·  PMID 40564239  ·  DOI
  2. 分析方法Analytical MethodsAnalytical evaluation and bioclinical validation of new aldosterone and renin immunoassays
    Clinical chemistry and laboratory medicine · 2022 · Coulon C et al.  ·  PMID 36096492  ·  DOI
  3. 分析方法Analytical MethodsDevelopment and validation of a method using supported liquid extraction for aldosterone determination in human plasma by LC-MS/MS
    Clinica chimica acta; international journal of clinical chemistry · 2015 · Meunier C et al.  ·  PMID 25982778  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSynthesis of aldosterone by mitochondria and homogeneous 11 beta-hydroxylase from beef and pig
    Endocrine research · 1991 · Hall PF et al.  ·  PMID 1879373  ·  DOI
  • 合成方法SynthesisSynthesis of 19-nor-aldosterone, 18-hydroxy-19-nor-corticosterone and 18,19-dihydroxycorticosterone in the human aldosterone-producing adenoma
    The Journal of steroid biochemistry and molecular biology · 1990 · Takeda Y et al.  ·  PMID 2278845  ·  DOI

醛固酮 —— 原料药与杂质对照品Aldosterone — drug substance & impurities

共 33 个条目(含原料药本体)33 items incl. the drug substance
Aldosterone structure
原料药 APIAPI
醛固酮Aldosterone
Aldosterone
CAS No.52-39-1
Chemical FormulaC21H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Tetrahydro Aldosterone structure
—
醛固酮杂质4 (四氢醛固酮)Tetrahydro Aldosterone
Tetrahydro Aldosterone
CAS No.13489-75-3
Chemical FormulaC21H32O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone 21-Acetate structure
—
醛固酮杂质1 (醛固酮21-醋酸盐)Aldosterone 21-Acetate
Aldosterone 21-Acetate
CAS No.2827-21-6
Chemical FormulaC23H30O6
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone 18-Glucuronide structure
—
醛固酮杂质23Aldosterone 18-Glucuronide
Aldosterone 18-Glucuronide
CAS No.3604-86-2
Chemical FormulaC27H36O11
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone 18-Oxime 21-Acetate structure
—
醛固酮杂质2Aldosterone 18-Oxime 21-Acetate
Aldosterone 18-Oxime 21-Acetate
CAS No.74220-49-8
Chemical FormulaC23H31NO6
Purity>95%询价On request
10mg25mg50mg100mg
1-Dehydroaldosterone structure
—
醛固酮杂质3 (脱氢醛固酮)1-Dehydroaldosterone
1-Dehydroaldosterone
CAS No.76959-24-5
Chemical FormulaC21H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Tetrahydro Aldosterone 3-beta-Glucuronide structure
—
Tetrahydro Aldosterone 3-beta-Glucuronide
CAS No.—
Chemical FormulaC27H40O11
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 1 structure
1
醛固酮杂质1Aldosterone Impurity 1
Aldosterone Impurity 1
CAS No.—
Chemical FormulaC27H36O9
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 2 structure
2
醛固酮杂质2Aldosterone Impurity 2
Aldosterone Impurity 2
CAS No.—
Chemical FormulaC27H36O9
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 3 structure
3
醛固酮杂质3Aldosterone Impurity 3
Aldosterone Impurity 3
CAS No.—
Chemical FormulaC23H30O7
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 4 structure
4
醛固酮杂质4Aldosterone Impurity 4
Aldosterone Impurity 4
CAS No.—
Chemical FormulaC27H38O11
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 8 structure
8
醛固酮杂质8Aldosterone Impurity 8
Aldosterone Impurity 8
CAS No.13479-36-2
Chemical FormulaC21H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 9 structure
9
醛固酮杂质9Aldosterone Impurity 9
Aldosterone Impurity 9
CAS No.19360-15-7
Chemical FormulaC21H32O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 10 structure
10
醛固酮杂质10Aldosterone Impurity 10
Aldosterone Impurity 10
CAS No.103232-21-9
Chemical FormulaC21H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 11 structure
11
醛固酮杂质11Aldosterone Impurity 11
Aldosterone Impurity 11
CAS No.103246-10-2
Chemical FormulaC21H28O6
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 12 structure
12
醛固酮杂质12Aldosterone Impurity 12
Aldosterone Impurity 12
CAS No.121699-10-3
Chemical FormulaC21H32O7S
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 13 structure
13
醛固酮杂质13Aldosterone Impurity 13
Aldosterone Impurity 13
CAS No.124251-89-4
Chemical FormulaC21H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 14 structure
14
醛固酮杂质14Aldosterone Impurity 14
Aldosterone Impurity 14
CAS No.147199-27-7
Chemical FormulaC21H28O6
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 15 structure
15
醛固酮杂质15Aldosterone Impurity 15
Aldosterone Impurity 15
CAS No.2507-88-2
Chemical FormulaC21H28O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 16 structure
16
醛固酮杂质16Aldosterone Impurity 16
Aldosterone Impurity 16
CAS No.89327-73-1
Chemical FormulaC20H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 17 structure
17
醛固酮杂质17Aldosterone Impurity 17
Aldosterone Impurity 17
CAS No.89327-63-9
Chemical FormulaC20H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 18 structure
18
醛固酮杂质18Aldosterone Impurity 18
Aldosterone Impurity 18
CAS No.3329-79-1
Chemical FormulaC25H32O7
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 19 structure
19
醛固酮杂质19Aldosterone Impurity 19
Aldosterone Impurity 19
CAS No.76025-75-7
Chemical FormulaC20H26O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 20 structure
20
醛固酮杂质20Aldosterone Impurity 20
Aldosterone Impurity 20
CAS No.74915-86-9
Chemical FormulaC27H44O5Si2
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 21 structure
21
醛固酮杂质21Aldosterone Impurity 21
Aldosterone Impurity 21
CAS No.70952-53-3
Chemical FormulaC21H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 24 structure
24
醛固酮杂质24Aldosterone Impurity 24
Aldosterone Impurity 24
CAS No.47417-48-1
Chemical FormulaC21H28O4
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 26 structure
26
醛固酮杂质26Aldosterone Impurity 26
Aldosterone Impurity 26
CAS No.52910-82-4
Chemical FormulaC25H32O8
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 27 structure
27
醛固酮杂质27Aldosterone Impurity 27
Aldosterone Impurity 27
CAS No.52036-29-0
Chemical FormulaC21H28O8S
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 28 structure
28
醛固酮杂质28Aldosterone Impurity 28
Aldosterone Impurity 28
CAS No.6005-92-1
Chemical FormulaC21H30O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 29 structure
29
醛固酮杂质29Aldosterone Impurity 29
Aldosterone Impurity 29
CAS No.6251-41-8
Chemical FormulaC21H32O5
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 30 structure
30
醛固酮杂质30Aldosterone Impurity 30
Aldosterone Impurity 30
CAS No.6251-70-3
Chemical FormulaC21H32O4
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 31 structure
31
醛固酮杂质31Aldosterone Impurity 31
Aldosterone Impurity 31
CAS No.93177-03-8
Chemical FormulaC21H26O4
Purity>95%询价On request
10mg25mg50mg100mg
Aldosterone Impurity 22-d8 structure
22-D8
醛固酮杂质22-d8Aldosterone Impurity 22-d8
Aldosterone Impurity 22-d8
CAS No.1261254-31-2
Chemical FormulaC21H20D8O5
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

醛固酮 —— 研究文献与合成路线Aldosterone — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 醛固酮 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Aldosterone. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Proteasome-mediated mineralocorticoid receptor degradation attenuates transcriptional response to aldosterone
    Yokota K, Shibata H, Kobayashi S, et al. · Endocrine research · 2004 · 被引 26cited 26
  2. Autophagic degradation of MVBs in LSECs promotes Aldosterone induced-HSCs activation
    Chen T, Zhang Y, Zhang Y, et al. · Hepatology international · 2024 · 被引 8cited 8
  3. [On the degradation and synthesis of aldosterone in pregnant and non-pregnant women]
    STARK G · Archiv fur Gynakologie · 1962 · 被引 2cited 2
  4. Beclin-1 restrains aldosterone signaling via autophagic degradation of the mineralocorticoid receptor to protect against cardiovascular injury
    Wang L, Jiang W, Zhang H, et al. · 2026
  5. Aldosterone inhibits EVs secretion through autophagic degradation of MVBs in LSECs leads to the activation of HSC
    Chen T, Zhang Y, Zhang Y, et al. · 2023
  6. Prospective validation of an automated chemiluminescence-based assay of renin and aldosterone for the work-up of arterial hypertension
    Rossi GP, Ceolotto G, Rossitto G, et al. · Clinical chemistry and laboratory medicine · 2016 · 被引 68cited 68

合成与制备工艺专利Synthesis & process patents

  1. REGULATION OF ALDOSTERONE SYNTHESIS FOR CONTROLLING HYPERTENSION
    BOSE HIMANGSHU S · 公开号 WO2009067484WO2009067484 · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

醛固酮 杂质谱研究要点Aldosterone — impurity profiling notes

下面这些是拿到 醛固酮 的 33 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 33 impurity entries for Aldosterone, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances